Catalyst Wire Dossier Catalyst Wire Dossier

Botulinum toxin type A (OnabotulinumtoxinA)

onabotulinumtoxinA · Allergan (AbbVie)
Drug timelines are a Plus or Pro feature.

7 regulatory and trial events tracked for Botulinum toxin type A (OnabotulinumtoxinA), covering 2008-05-28 to 2026-03-17. Get the full timeline:

Most recent: Clinical Trial Update: Dual-Site Botulinum Toxin Type A Injection for Lifelong Premature Ejaculation [NA]

See pricing